机构:[1]Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (CapitalMedical University), Key Laboratory of Major Diseases in Children, Ministry of Education[2]Hematology Oncology Center, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China医技科室职能科室临床流行病与循证医学中心血液中心首都医科大学附属北京儿童医院[2]Hematology and Oncology Laboratory, Beijing Pediatric Research Institute, Beijing Children’s Hospital, CapitalMedical University, National Center for Children’s Health, Beijing Key Laboratory of Pediatric Hematology Oncology, Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics, Beijing, China医技科室科研平台职能科室临床流行病与循证医学中心血液疾病研究室血液中心儿科研究所首都医科大学附属北京儿童医院
第一作者机构:[1]Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (CapitalMedical University), Key Laboratory of Major Diseases in Children, Ministry of Education
通讯作者:
通讯机构:[1]Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (CapitalMedical University), Key Laboratory of Major Diseases in Children, Ministry of Education[*1]Department of Hematology and Oncology, Beijing Children’s Hospital, Capital Medical University, Nanlishi Road No. 56, Xicheng District, Beijing 100045, China.
推荐引用方式(GB/T 7714):
Wei Ang,Ma Honghao,Li Zhigang,et al.Successful treatment of a child with idiopathic multicentric Castleman disease associated with hemophagocytic lymphohistiocytosis using tocilizumab[J].PEDIATRIC BLOOD & CANCER.2019,66(7):-.doi:10.1002/pbc.27759.
APA:
Wei, Ang,Ma, Honghao,Li, Zhigang,Zhang, Liping,Zhang, Rui&Wang, Tianyou.(2019).Successful treatment of a child with idiopathic multicentric Castleman disease associated with hemophagocytic lymphohistiocytosis using tocilizumab.PEDIATRIC BLOOD & CANCER,66,(7)
MLA:
Wei, Ang,et al."Successful treatment of a child with idiopathic multicentric Castleman disease associated with hemophagocytic lymphohistiocytosis using tocilizumab".PEDIATRIC BLOOD & CANCER 66..7(2019):-